Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients
Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients
The purpose of this study is to determine whether micronized trans-resveratrol improves
 clinical (excessive hair, menstrual cycle), endocrine (androgens)and metabolic (lipids,
 markers of systemic inflammation) in women with polycystic ovary syndrome (PCOS).
Inclusion Criteria:

 -  PCO - Androgen Excess Society criteria: hyperandrogenism (hirsutism) /
 hyperandrogenemia (testosterone >70ng/dl) and/or oligomenorrhea (<8 spontaneous menses
 per year) and/or polycystic ovarian morphology on ultrasound

 -  Normal prolactin, TSH, 17-OH progesterone

 -  No evidence of androgen producing malignancy, Cushing's syndrome or acromegaly

 -  Age 18-40

 Exclusion Criteria:

 -  Use of oral contraceptives and/or other steroid hormones 3 months prior to the study